Abstract Details
|
Mark Mapstone, PhD
(University of California, Irvine)
PRESENTER |
Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brain Neurotherapy Bio, Inc. Dr. Mapstone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon, Inc. Dr. Mapstone has received intellectual property interests from a discovery or technology relating to health care. |
| Massimo Fiandaca | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Claudia Kawas, MD (University of California, Irvine) | The institution of Dr. Kawas has received research support from NIH. |
| Howard J. Federoff, MD, PhD (University of California, Irvine) | No disclosure on file |